Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quidelortho Corp (NQ: QDEL )

89.09 +1.01 (+1.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 285,266
Open 88.58
Bid (Size) 86.61 (1)
Ask (Size) 91.65 (1)
Prev. Close 88.08
Today's Range 88.58 - 90.23
52wk Range 66.88 - 120.61
Shares Outstanding 41,632,759
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
From QuidelOrtho Corporation
Via Business Wire

Performance

YTD
+4.81%
+4.81%
1 Month
+4.25%
+4.25%
3 Month
+3.99%
+3.99%
6 Month
+24.64%
+24.64%
1 Year
-20.78%
-20.78%

More News

Read More
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference
From QuidelOrtho Corporation
Via Business Wire
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
4 Analysts Have This to Say About QuidelOrtho
Via Benzinga
Newly Combined Quidel/Ortho Clinical Expects Better Than Expected Q3 Sales
Via Benzinga
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
SMID Cap Life Science Update: Are You An Investor Or Trader?
Via Talk Markets
QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
From QuidelOrtho Corporation
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
QuidelOrtho to Present at the J.P. Morgan Healthcare Conference
From QuidelOrtho Corporation
Via Business Wire
Billionaire David Rubenstein Is Betting Big on ZoomInfo (ZI) Stock
Via InvestorPlace
QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles
From QuidelOrtho Corporation
Via Business Wire
QuidelOrtho to Host Investor Day on December 13, 2022
From QuidelOrtho Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Why QuidelOrtho Stock Slipped and Fell Today
Via The Motley Fool
QuidelOrtho Reports Third Quarter 2022 Financial Results
From QuidelOrtho Corporation
Via Business Wire
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
Via Benzinga
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
From QuidelOrtho Corporation
Via Business Wire
Development of New Drugs to Target Lyme and Other Infectious Diseases Subject of a New Webinar Now Available From Quidel Corporation
From Quidel Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.